logo
Plus   Neg
Share
Email

Elanco Animal Health Narrows FY19 Outlook Range - Quick Facts

While reporting financial results for the second quarter on Tuesday, Elanco Animal Health Inc. (ELAN) narrowed its adjusted earnings and revenue guidance range for the full-year 2019. This primarily reflects the increased headwind from African Swine Fever and anticipated supply disruption of certain injectable cattle products offset by the positive impact from business development actions.

For fiscal 2019, the company now projects adjusted earnings in the range of $1.04 to $1.10 per share on net sales between $3.08 billion and $3.12 billion.

Previously, the company expected adjusted earnings in the range of $1.02 to $1.12 per share on net sales between $3.08 billion and $3.14 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $1.09 per share on net sales of $3.11 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

RELATED NEWS
Follow RTT
>